日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oncolytic virus M1 reinvigorates CD8(+) T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen.

溶瘤病毒 M1 通过脾脏中 B 细胞依赖性抗原交叉呈递,重新激活 CD8(+) T 细胞对胶质母细胞瘤的免疫力。

Han Yu, Guo Cui, Chen Chaoxin, Yang Wenzhuo, Li Honghui, He Changjia, Deng Jialin, Chen Zhijie, Liu Wenfeng, Chen Jiehong, Zhong Yingqian, Yan Caixin, Xu Cuiying, Liang Xuanming, Zhong Sheng, Chen Furong, Li Depei, Li Cong, Hu Wanming, Chen Zhenghe, Mou Yonggao, Chen Zhongping, Yan Guangmei, Lim Michael, Zhu Wenbo, Sai Ke

SRSF1 haploinsufficiency drives the neurodevelopmental phenotype of the 17q22 deletion syndrome

SRSF1单倍体不足是17q22缺失综合征神经发育表型的驱动因素。

Wu, Youlan; Gao, Chuanfen; Chen, Zhenghe; Liu, Fang; Yuan, Jing; Cheng, Weisheng

Genomic landscape and immunological profile of glioblastoma in East Asian patients.

东亚胶质母细胞瘤患者的基因组图谱和免疫学特征

Zhong Sheng, Wu Bo, Dubois Frank, Deng Davy, Bergholz Johann S, Hu Wanming, Duan Hao, Shao Yujie, Liu Jingyi, Liu Luwei, Chen Sitong, Hu Yongfei, Zhao Zheng, Yao Maojin, Sai Ke, Wang Jian, Chen Yinsheng, Ke Chao, Zhang Xiangheng, Yang Qunying, Guo Chengcheng, Zhang Ji, Lin Fuhua, Chen Zhenghe, Li Deipei, He Zhenqiang, Li Chang, Jiang Xiaobing, Lu Jie, Yang Wenzhuo, Jiang Tao, Chen Zhongping, Beroukhim Rameen, Zhao Jean J, Mou Yonggao

VAL-083 is effective in patients with newly-diagnosed MGMT-unmethylated glioblastoma: report of phase II study

VAL-083 对新诊断的 MGMT 未甲基化胶质母细胞瘤患者有效:II 期研究报告

Guo, Chengcheng; Yang, Qunying; Deng, Meiling; Qiu, Xiaoling; Wu, Shaoxiong; Du, Xiaojing; Sai, Ke; Dai, Ziyu; Chen, Zhenghe; Zhang, Ji; Lin, Fuhua; Ke, Chao; Xi, Shaoyan; Hu, Wanming; Zhou, Zhihuan; Li, Jiawei; Cao, Xi; Liao, Yixiang; Lv, Yanchun; Brown, Dennis; Langlands, John; Johnson, Gregory; Bacha, Jeffrey; Kwan, Claire; Kanekal, Sarath; Schwartz, Richard; Chen, Zhongping

Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up.

恶性胶质瘤局部免疫治疗后的长期生存率:一项回顾性研究,随访时间长达 20 年

Duan Hao, He Zhenqiang, Chen Zhenghe, Chen Yukun, Hu Wanming, Sai Ke, Zhang Xiangheng, Xia Jianchuan, Li Yongqiang, Liu Ranyi, Zou Chaowei, Chen Zhongping, Mou Yonggao

Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial

替莫唑胺辅助化疗联合或不联合干扰素α治疗新诊断的高级别胶质瘤患者:一项随机临床试验

Guo, Chengcheng; Yang, Qunying; Xu, Pengfei; Deng, Meiling; Jiang, Taipeng; Cai, Linbo; Li, Jibin; Sai, Ke; Xi, Shaoyan; Ouyang, Hui; Liu, Mingfa; Li, Xianming; Li, Zihuang; Ni, Xiangrong; Cao, Xi; Li, Cong; Wu, Shaoxiong; Du, Xiaojing; Su, Jun; Xue, Xiaoying; Wang, Yiming; Li, Gang; Qin, Zhiyong; Yang, Hui; Zhou, Tao; Liu, Jinquan; Hu, Xuefeng; Wang, Jian; Jiang, Xiaobing; Lin, Fuhua; Zhang, Xiangheng; Ke, Chao; Lv, Xiaofei; Lv, Yanchun; Hu, Wanming; Zeng, Jing; Chen, Zhenghe; Zhong, Sheng; Wang, Hairong; Chen, Yinsheng; Zhang, Ji; Li, Depei; Mou, Yonggao; Chen, Zhongping

Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis

改良全身炎症评分在非小细胞肺癌脑转移中的预后价值

Wang, Feng; Chen, Limin; Wang, Zhao; Xu, Qiuyan; Huang, He; Wang, Hairong; Li, Xi; Yu, Mingjie; Chen, Jiangen; Lin, Fuhua; Chen, Zhenghe; Zhang, Xiangheng; Yang, Qunying; Mou, Yonggao; Guo, Chengcheng

Prognostic Value of the Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Patients With Medulloblastoma Undergoing Surgical Resection

系统性免疫炎症指数和预后营养指数在接受手术切除的髓母细胞瘤患者中的预后价值

Zhu, Sihan; Cheng, Zhuqing; Hu, Yuanjun; Chen, Zhenghe; Zhang, Ji; Ke, Chao; Yang, Qunying; Lin, Fuhua; Chen, Yinsheng; Wang, Jian

Effective natural inhibitors targeting poly ADP-ribose polymerase by computational study

通过计算研究发现靶向聚ADP核糖聚合酶的有效天然抑制剂

Zhong, Sheng; Wu, Bo; Yang, Wenzhuo; Ge, Junliang; Zhang, Xiangheng; Chen, Zhenghe; Duan, Hao; He, Zhenqiang; Liu, Yibing; Wang, Hongyu; Jiang, Yuting; Zhang, Zhiyun; Wang, Xinhui; Li, Weihang; Liu, Naimeng; Guo, Xiaoyu; Mou, Yonggao

Computational study on novel natural inhibitors targeting BCL2

针对BCL2的新型天然抑制剂的计算研究

Lv, Xiaye; Jiang, Yuting; Wang, Xinhui; Xie, HaoQun; Dou, Gaojing; Wang, Jing; Yang, Wenzhuo; Wang, Hongyu; Li, Zijian; Zhang, Xiangheng; Chen, Zhenghe